Metabolic dysfunction-associated steatotic liver disease
As the prevalence of obesity increases globally, the incidence of metabolic dysfunction-associated steatotic liver disease (MASLD) also increases in both developed and developing countries. However, the MASLD phenotype remains unclear, with many unknown reasons. Since Ludwig and others coined the te...
Saved in:
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2024-12-01
|
Series: | Tungs’ Medical Journal |
Subjects: | |
Online Access: | https://doi.org/10.4103/ETMJ.ETMJ-D-24-00019 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|